🇺🇸 FDA
Patent

US 6632789

Methods for modulating T cell responses by manipulating intracellular signal transduction

expired A61KA61K31/00A61K31/35

Quick answer

US patent 6632789 (Methods for modulating T cell responses by manipulating intracellular signal transduction) held by United States of America as represented by the Secretary of the Air Force expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/00, A61K31/35, A61K31/365, A61P